Financials in USD. Standardized financial statements.
A compact view of how scPharmaceuticals Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $36.33M | $13.59M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | +167.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $11.36M | $3.81M | $468,000 | $438,000 | $399,000 | $364,000 | $332,000 | $167,000 | $5,000 | $4,000 |
| Gross Profit? | $24.97M | $9.78M | -$468,000 | -$438,000 | -$399,000 | -$364,000 | -$332,000 | -$167,000 | -$5,000 | -$4,000 |
| Gross Margin? | +68.7% | +72.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $89.75M | $65.18M | $36.16M | $25.82M | $29.93M | $32.91M | $29.67M | $23.44M | $17.91M | $10.84M |
| Operating Income? | -$64.78M | -$55.40M | -$36.16M | -$25.82M | -$29.93M | -$32.91M | -$29.67M | -$23.44M | -$17.91M | -$10.84M |
| EBITDA? | -$77.43M | -$46.06M | -$33.07M | -$25.02M | -$29.22M | -$30.86M | -$27.68M | -$25.15M | -$17.86M | -$10.84M |
| Income Before Tax | -$85.15M | -$54.81M | -$36.84M | -$28.03M | -$32.21M | -$33.00M | -$29.44M | -$23.82M | -$24.38M | -$10.52M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$224,000 | $0 | $0 | $0 |
| Net Income? | -$85.15M | -$54.81M | -$36.84M | -$28.03M | -$32.21M | -$34.41M | -$29.44M | -$23.82M | -$24.38M | -$10.52M |
| EPS? | $-1.91 | $-1.42 | $-1.30 | $-1.02 | $-1.31 | $-1.85 | $-1.59 | $-8.04 | $-2.18 | $-0.94 |
| Diluted EPS? | $-1.91 | $-1.42 | $-1.30 | $-1.02 | $-1.31 | $-1.85 | $-1.59 | $-8.04 | $-2.18 | $-0.94 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality